Impel Pharmaceuticals Inc. (NASDAQ:IMPL) Q4 2022 Earnings Call Transcript March 24, 2023
Operator: Good morning, ladies and gentlemen and welcome to Impel Pharmaceuticals Fourth Quarter and Full Year 2022 Earnings and Business Update Conference Call. As a reminder, today’s conference is being recorded. I would now like to turn the conference over to Impel’s Chairman and Chief Executive Officer, Mr. Adrian Adams. Please go ahead, sir.
Adrian Adams: Thank you, operator and good morning,...
